Oxford Instruments (OXIG) AI Stock Analysis

• Market Cap: $918.86M
• Dividend Yield: 1.27%
• Average Volume (3M): 145.77K
• Price to Earnings (P/E): 17.5
• Beta (1Y): 1.30
• Revenue Growth: 7.18%
• EPS Growth: -13.14%
• Country: UK
• Employees: 2,000
• Sector: Technology
• Sector Strength: 49
• Industry: Semiconductors
• EPS (TTM): 0.91
• Shares Outstanding: 58,134,773
• 10 Day Avg. Volume: 221,803
• 30 Day Avg. Volume: 145,771
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 2.32
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: 2,432.68p
• Price Target Upside: 53.77% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

Oxford Instruments maintains strong financial health with consistent revenue growth and robust profitability. However, bearish technical indicators suggest caution in the short term. The stock is reasonably valued with a moderate P/E ratio and modest dividend yield. Recent corporate events imply positive future prospects, but their impact is not included in the overall score.

Positive Factors

Cost Management

OXIG has taken £1.2m of cost out of its Quantum business.

Market Engagement

Oxford continues to be a stock on which there is high investor engagement.

Profitability

Advanced Technologies is expected to return to profitability, with the CFO stating that absent of the stock provision, the division would have been break even.

Negative Factors

Exchange Rate Impact

Oxford Instruments is impacted by foreign exchange, leading to a downgrade in EBITA expectations.

Financial Performance

OXIG's stock has reacted poorly to the morning's numbers, attributed to a greater weighting than envisaged in consensus numbers and weak cash conversion.

Order Performance

Orders in Advanced Manufacturing saw a decrease, with weaker OEM X-Ray orders impacting performance.

Oxford Instruments Business Overview & Revenue Model

Company Description

Oxford Instruments plc provides technology products and services in Europe, North America, Asia, and internationally. It operates through three segments: Materials & Characterisation, Research & Discovery, and Service & Healthcare. The company offers atomic force microscopy products; tools for use in research and development across a range of applications, including semiconductors, renewable energy, mining, metallurgy, and forensics; etch and deposition processing equipment and solutions for use in power and RF devices, VCSELs/lasers, 2D materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS and sensors, and quantum; and low temperature systems comprising wet systems, dry systems, magnets, cryogenics, and accessories. It also provides optical imaging products; and nuclear magnetic resonance (NMR) instruments, including NMR spectrometers, QC/QA analyzers, and rock core analyzers. In addition, the company offers; scientific cameras, spectroscopy solutions, microscopy systems, and software; and manufactures x-ray tubes, power supplies, and integrated x-ray sources for analytical, medical imaging, food quality and packaging inspection, and industrial NDT markets. Its products are used in various industries, such as advanced manufacturing, agriculture and food, astronomy, automotive and aerospace, bio imaging and life science, chemical and catalysis, energy generation and storage, forensics and environment, geology, petrology, mining, metals, alloys, composites, ceramics, pharma, photonics, quantum technologies, semiconductors, microelectronics, and data storage. Oxford Instruments plc was founded in 1959 and is headquartered in Abingdon, the United Kingdom.

How the Company Makes Money

Oxford Instruments generates revenue through the sale of its high-tech equipment and instrumentation to a diverse customer base that includes academic institutions, research facilities, and industrial companies. Key revenue streams include the sales of capital equipment, ongoing service contracts, and software solutions that complement their hardware offerings. The company also benefits from strategic partnerships and collaborations with leading research organizations and industrial partners, which enhance its market position and drive sales across its product portfolio.

Oxford Instruments Financial Statement Overview

Summary

Oxford Instruments demonstrates a strong financial position with consistent revenue growth and solid profitability margins. The balance sheet is robust with low leverage, but there are challenges in free cash flow generation, which slightly moderates the overall financial performance score.

Income Statement

Oxford Instruments shows a strong financial performance with a consistent upward trend in revenue, as evidenced by a Revenue Growth Rate of 5.77% from 2023 to 2024. The Gross Profit Margin is robust at 51.53%, and the company maintains a healthy Net Profit Margin of 10.78%. The EBIT Margin of 14.52% and EBITDA Margin of 19.79% indicate efficient operations and good profitability potential.

Balance Sheet

The company has a solid balance sheet with a Debt-to-Equity Ratio of 0.13, indicating low leverage, which reduces financial risk. The Return on Equity is impressive at 13.86%, showcasing effective management in generating profits from equity. The Equity Ratio of 60.30% suggests a strong equity base relative to assets, providing stability.

Cash Flow

Oxford Instruments displays moderate cash flow management with some areas for improvement. The Free Cash Flow Growth Rate declined by 57.65% from 2023 to 2024, highlighting potential issues in cash generation. However, the Operating Cash Flow to Net Income Ratio of 0.84 and Free Cash Flow to Net Income Ratio of 0.29 suggest reasonable cash conversion efficiency.

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
470.40M	444.70M	367.30M	318.50M	317.40M
	Gross Profit
242.40M	219.50M	176.40M	153.90M	146.70M
	EBIT
68.30M	66.70M	50.80M	47.40M	40.70M
	EBITDA
93.10M	94.80M	67.40M	71.60M	58.00M
	Net Income Common Stockholders
50.70M	58.60M	38.60M	41.80M	33.80M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
97.80M	112.70M	96.40M	128.00M	119.50M
	Total Assets
606.30M	572.00M	514.00M	450.70M	464.00M
	Total Debt
47.40M	43.90M	28.90M	37.90M	60.60M
	Net Debt
-50.40M	-68.80M	-67.50M	-90.10M	-58.90M
	Total Liabilities
240.60M	228.00M	197.60M	184.50M	212.40M
	Stockholders Equity
365.70M	344.00M	316.40M	266.20M	251.60M
Cash Flow		Free Cash Flow
14.70M	34.70M	34.50M	36.70M	48.00M
	Operating Cash Flow
42.40M	67.60M	49.20M	41.80M	55.20M
	Investing Cash Flow
-37.50M	-37.50M	-45.70M	-4.90M	14.70M
	Financing Cash Flow
-18.00M	-16.60M	-15.70M	-30.50M	-11.40M

Oxford Instruments Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1582.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:OXIG, the sentiment is Negative. The current price of 1582 is below the 20-day moving average (MA) of 1744.50, below the 50-day MA of 1868.50, and below the 200-day MA of 2097.05, indicating a bearish trend. The MACD of -98.30 indicates Positive momentum. The RSI at 33.60 is Neutral, neither overbought nor oversold. The STOCH value of 22.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:OXIG.

Oxford Instruments Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DPLM	66 Neutral	£5.08B	39.26	14.50%	1.57%	13.59%	6.14%
JMAT	66 Neutral	£1.97B	4.05	21.80%	6.53%	-15.51%	200.70%
OXIG	65 Neutral	$918.86M	17.46	14.23%	1.27%	7.18%	-13.14%
SXS	64 Neutral	£1.94B	8.38	17.33%	4.12%	-11.09%	65.87%
CRDA	62 Neutral	£3.68B	23.18	6.84%	4.14%	-3.92%	-7.32%
Sector *	57 Neutral	$19.95B	9.66	-12.09%	2.76%	5.40%	-24.89%
RCDO	52 Neutral	£140.57M	205.36	-5.28%	4.69%	-8.12%	-794.85%

Oxford Instruments Corporate Events

Oxford Instruments Sees Shift in Major Shareholdings

Oxford Instruments PLC has announced a change in major holdings, as Aberdeen Group plc has crossed the 5% threshold of voting rights, now holding 5.263333% of the company’s voting rights. This acquisition of voting rights by Aberdeen Group plc signifies a notable shift in shareholder dynamics, potentially impacting the company’s governance and strategic direction.

Spark’s Take on GB:OXIG Stock

According to Spark, TipRanks’ AI Analyst, GB:OXIG is a Neutral.

Oxford Instruments maintains strong financial health with consistent revenue growth and robust profitability. However, bearish technical indicators suggest caution in the short term. The stock is reasonably valued with a moderate P/E ratio and modest dividend yield. Recent corporate events imply positive future prospects, but their impact is not included in the overall score.

To see Spark’s full report on GB:OXIG stock, click here.

Oxford Instruments Announces Share Capital Details

Oxford Instruments has announced that as of March 31, 2025, its issued share capital with voting rights consists of 58,134,773 ordinary shares. This figure is significant for shareholders as it serves as the denominator for calculating their interest or changes in interest under the FCA’s Disclosure Guidance and Transparency Rules.

Artemis Investment Management Increases Stake in Oxford Instruments

Artemis Investment Management LLP has increased its stake in Oxford Instruments PLC, crossing a significant threshold of 12.12% of voting rights as of March 21, 2025. This acquisition of voting rights by a major investment firm indicates a strengthened position in the company, potentially impacting its governance and strategic decisions.

BlackRock Adjusts Stake in Oxford Instruments

BlackRock, Inc., a major shareholder in Oxford Instruments PLC, has adjusted its holdings, reducing its total voting rights from 10.94% to 9.97%. This change in holdings, effective as of March 4, 2025, reflects a strategic shift in BlackRock’s investment approach, potentially impacting Oxford Instruments’ shareholder dynamics and market perception.

Artemis Increases Stake in Oxford Instruments

Artemis Investment Management LLP has increased its voting rights in Oxford Instruments PLC to 11.041235%, up from a previous position of 10.010264%. This change in holdings reflects a strategic move by Artemis, potentially impacting the company’s shareholder dynamics and influencing its future governance and decision-making processes.

Oxford Instruments Executives Acquire Shares Under Incentive Plan

Oxford Instruments plc announced the acquisition of partnership and matching shares by its CEO Richard Tyson and CFO Gavin Hill under the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, aligns with the company’s regulatory compliance under the EU Market Abuse Regulation, potentially impacting the company’s governance and stakeholder confidence.

Oxford Instruments Updates Shareholders on Voting Rights and Capital

Oxford Instruments announced that as of 28 February 2025, its issued share capital with voting rights consists of 58,093,163 ordinary shares. This figure is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.

Oxford Instruments Strengthens Board with New Independent Director

Oxford Instruments plc announced the appointment of Rowena Innocent as an Independent Non-Executive Director. Joining the board from February 17, 2025, Innocent will also become a member of several key committees. With over 30 years of experience in high-tech product design and manufacturing, her expertise is expected to significantly enhance the company’s engineering, research, and development pursuits, contributing to its core business objectives.

Oxford Instruments’ Executives Acquire Shares in Incentive Plan

Oxford Instruments plc announced a transaction involving its Chief Executive Officer Richard Tyson and Chief Financial Officer Gavin Hill, who both acquired Partnership Shares and Matching Shares in the company’s Share Incentive Plan. The transaction, conducted on 10 February 2025 at the London Stock Exchange, reflects the management’s confidence in the company, potentially influencing stakeholder perception positively. The company made this announcement in compliance with the EU Market Abuse Regulation, underscoring its commitment to transparency and regulatory adherence.